Literature DB >> 6313123

Biochemical identification of multiple GABAB binding sites: association with noradrenergic terminals in rat forebrain.

E W Karbon, R Duman, S J Enna.   

Abstract

GABAA (bicuculline-sensitive) and GABAB (bicuculline-insensitive) receptor binding were examined in an attempt to determine whether either site was present on noradrenergic terminals in rat brain cerebral cortex. Equilibrium binding saturation studies revealed the presence of two GABAB binding sites in brain tissue, with affinity constants of 60 and 229 nM. Regional distribution studies in the cow brain revealed that the ratio of the high and low affinity GABAB binding sites differed among the areas examined. Both GABAA and GABAB binding were examined in the rat brain cortex 12 days following a unilateral lesion of the dorsal noradrenergic bundle. While GABAA and high affinity GABAB binding were unaffected by the lesion, the number of low affinity GABAB sites was significantly reduced. These results indicate that high and low affinity GABAB binding sites may be anatomically distinct, with only the latter being associated with cerebral cortical noradrenergic nerve terminals.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6313123     DOI: 10.1016/0006-8993(83)90725-4

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  10 in total

1.  Differential coupling of GABA-A and GABA-B receptors to the noradrenergic system.

Authors:  P D Suzdak; G Gianutsos
Journal:  J Neural Transm       Date:  1985       Impact factor: 3.575

2.  GABA-noradrenergic interaction: evidence for differential sites of action for GABA-A and GABA-B receptors.

Authors:  P D Suzdak; G Gianutsos
Journal:  J Neural Transm       Date:  1985       Impact factor: 3.575

3.  Evidence for GABAB-receptors on cultured astrocytes of rat CNS: autoradiographic binding studies.

Authors:  E Hösli; L Hösli
Journal:  Exp Brain Res       Date:  1990       Impact factor: 1.972

4.  Effects of the putative antagonists phaclofen and delta-aminovaleric acid on GABAB receptor biochemistry.

Authors:  T N Robinson; A J Cross; A R Green; J M Toczek; B R Boar
Journal:  Br J Pharmacol       Date:  1989-11       Impact factor: 8.739

Review 5.  Baclofen reduces post-synaptic potentials of rat cortical neurones by an action other than its hyperpolarizing action.

Authors:  J R Howe; B Sutor; W Zieglgänsberger
Journal:  J Physiol       Date:  1987-03       Impact factor: 5.182

6.  On central muscle relaxants, strychnine-insensitive glycine receptors and two old drugs: zoxazolamine and HA-966.

Authors:  B A McMillen; H L Williams; H Lehmann; P D Shepard
Journal:  J Neural Transm Gen Sect       Date:  1992

7.  Lack of effect of bilateral locus coeruleus lesion and antidepressant treatment on gamma-aminobutyric acidB receptors in the rat frontal cortex.

Authors:  A H Engelbrecht; V A Russell; J J Taljaard
Journal:  Neurochem Res       Date:  1994-09       Impact factor: 3.996

8.  The locomotor-reducing effects of GABAergic drugs do not depend on the GABAA receptor.

Authors:  A Agmo; M Giordano
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

9.  GABAergic effects of reserpine following chronic treatment.

Authors:  P D Suzdak; G Gianutsos
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

10.  Repeated administration of desipramine and a GABAB receptor antagonist, CGP 36742, discretely up-regulates GABAB receptor binding sites in rat frontal cortex.

Authors:  G D Pratt; N G Bowery
Journal:  Br J Pharmacol       Date:  1993-10       Impact factor: 8.739

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.